Fig. 1 (abstract P153).From: 32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part OneMLR with VIP and VIPhyb-NP. (A,B) Proliferation of luciferase+ B6 splenic T cells cultured for 3 days in MLR with FVB splenocytes, with daily addition of VIP and VIPhyb-NP in concentrations of 0-975 μg/mL. MLRs were initiated with 400,000 cells/well for both cell types, and bioluminescence measured with imaging on day 3.Back to article page